Get startedLog in
    Picture of Zynerba Pharmaceuticals logo

    ZYNE — Zynerba Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall Cap
    All News

    Brief: Zynerba Pharmaceuticals Announces Top Line Results From Pivotal Connect-FX Trial Of Zygel

    Picture of Zynerba Pharmaceuticals logoZynerba Pharmaceuticals
    30/06/2020 12:26
    June 30 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS ANNOUNCES TOP LINE RESULTS FROM
PIVOTAL
CONNECT-FX TRIAL OF ZYGEL™ (CBD GEL) IN FRAGILE X SYNDROME
    * ZYNERBA PHARMACEUTICALS INC - STUDY DID NOT ACHIEVE
STATISTICAL
SIGNIFICANCE IN PRIMARY OR KEY SECONDARY ENDPOINTS IN FULL
ANALYSIS SET

Source text for Eikon:  ID:nGNXPYpfw 
Further company coverage:  ZYNE.O 

 ((Briefs@thomsonreuters.com;))

    Recent news on Zynerba Pharmaceuticals

    See all news